FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100100 [Registered on: 01/01/2026] Trial Registered Prospectively
Last Modified On: 27/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare which treatment option is better in Tennis Elbow patients Platelet Rich Plasma (PRP) injection or Steroid (Triamcinolone acetate) injection 
Scientific Title of Study   Comparison of Effectiveness of injection Triamcinolone Acetate vs Platelet Rich Plasma (PRP) in management of Lateral Epicondylitis (Tennis Elbow) Patients A Randomized controlled trail 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amit Thakur 
Designation  Associate Professor 
Affiliation  AIIMS JAMMU 
Address  Department of Orthopaedics, Unit 1, Room No 232, OPD 2nd Floor, AIIMS Jammu, Vijaypur

Jammu
JAMMU & KASHMIR
184120
India 
Phone  184120  
Fax    
Email  Amit.thakur@aiimsjammu.edu.in  
 
Details of Contact Person
Scientific Query  
Name  Dr Amit Thakur 
Designation  Associate Professor 
Affiliation  AIIMS JAMMU 
Address  Department of Orthopaedics, Unit 1, Room No 232, OPD 2nd Floor, AIIMS Jammu, Vijaypur

Jammu
JAMMU & KASHMIR
184120
India 
Phone  184120  
Fax    
Email  Amit.thakur@aiimsjammu.edu.in  
 
Details of Contact Person
Public Query  
Name  Dr Amit Thakur 
Designation  Associate Professor 
Affiliation  AIIMS JAMMU 
Address  Department of Orthopaedics, Unit 1, Room No 232, OPD 2nd Floor, AIIMS Jammu, Vijaypur

Jammu
JAMMU & KASHMIR
184120
India 
Phone  184120  
Fax    
Email  Amit.thakur@aiimsjammu.edu.in  
 
Source of Monetary or Material Support  
AIIMS Jammu, Vijaypur - 184120, India 
 
Primary Sponsor  
Name  AIIMS JAMMU 
Address  AIIMS Jammu, Vijaypur - 184120, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Roobal Ramdass  AIIMS JAMMU  Department of Orthopaedics, Unit 1, Room No 232, OPD 2nd Floor, AIIMS Jammu, Vijaypur
Jammu
JAMMU & KASHMIR 		 7888932288

roobal.ramdass@aiimsjammu.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, AIIMS Jammu  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M771||Lateral epicondylitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Injection Platelet rich plasma  1ml at most tender point inside the tendon Duration for 9 months 
Intervention  Injection Triamcinolone Acetate   40mg at most tender point around ECRB tendon Duration for 9 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Participants were included if they met the following criteria:
1. Diagnosis of chronic lateral epicondylitis of the elbow based on clinical examination. This was defined by: a. Pain on palpation of the lateral epicondyle, and b. Pain during resisted wrist extension or supination of the forearm.
2. Symptoms lasting at least 6 months.3. Failure of conservative treatment, including physiotherapy, nonsteroidal anti-inflammatory drugs (NSAIDs), and rest.
4. Age between 18 and 60 years. 5. No previous injections at the affected elbow. 6. Patient consent to participate in the study. 
 
ExclusionCriteria 
Details  Participants were excluded if they presented with any of the following:
1. Bilateral elbow symptoms. 2. Involvement of the cervical spine or shoulder (which could refer pain to the elbow).
3. Rheumatoid arthritis or other inflammatory arthropathy. 4. Coagulopathy (blood clotting disorder). 5. Prior surgery on the affected elbow. 6. Chronic use of corticosteroids. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Dates of Birth or day of the Week 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Pain intensity: VAS score (0-10)  At Baseline, 1,3,6 months followup 
 
Secondary Outcome  
Outcome  TimePoints 
Functional Disability: PRTEE (0-100)
Adverse events: incidence and severity recorded at each follow up 		 At Baseline, 1,3,6 months followup 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Current management of Lateral Epicondylitis (LE) ranges from conservative methods (rest, bracing, physiotherapy, NSAIDs) to injections and surgery. Corticosteroids, like Triamcinolone acetate, are common for rapid short-term pain relief due to their potent anti-inflammatory properties. However, recent randomized controlled trials show that while PRP provides sustained benefits over 3-24 months, corticosteroid effects often diminish.
Despite this, a definitive consensus on the comparative efficacy in Lateral Epicondylitis remains inconclusive.
Therefore, a well-designed, adequately powered, randomized controlled trial is needed to directly compare Triamcinolone acetate and PRP in chronic Lateral Epicondylitis patients. This study aims to:
• Clarify comparative efficacy
• Inform clinical decision-making: Provide evidence-based guidance for Lateral Epicondylitis treatment.
• Assess safety profiles: Compare adverse events of both injection types.
Ultimately, this research will significantly strengthen the evidence base for Lateral Epicondylitis management, improving patient care and optimizing treatment strategies for this common condition.
 
Close